🟢 80/100

This product is generally safe

  • Vitamin D: 0.125mg is 1.2× the Tolerable Upper Intake Level (0.1mg)
  • 50% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Vitamin D: 0.125mg is 1.2× the Tolerable Upper Intake Level (0.1mg)

Label Data

1 Capsule(s) Serving Size
60 Servings
Vitamin Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

125 mcg (625% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 1.2× (UL: 0.1 mg) 📚 604 studies (Tier A: 16, B: 251)
RDA 0.015mg This product: 0.125mg UL 0.1mg
MenaquinGold
200 mcg

Other Ingredients

Cellulose Cellulose Water Maltodextrin Tocopherols Medium Chain Triglyceride

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Vegetarian Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Directions: Ages 18+ take 1 capsule daily with food or as recommended by a healthcare practitioner.

⚠️ Warnings & Precautions

Caution: Do not exceed recommended dose. Use only if safety seal is intact.

If you are taking anti-coagulant, anti-platelet medications, or have a bleeding disorder, consult with your healthcare provider before taking this product. If you are pregnant or nursing, taking any medication condition, consult with your doctor before using any dietary supplement.

Keep out of reach of children.

🧪 Formulation Notes

Vitamin D drives cognitive health, bone health, immune function and more. Vitamin K2 helps your body use calcium properly which impacts cardiovascular health and bone density. Individually they're crucial, but they're even better when paired together. Vitamin K2-7 plus D3 offers high potency K2-7 and D3 for synergistic total body health support.

High potency Supports healthy Immunity Bones Cardiovascular function

Vegetarian

Gluten free Dairy free Non GMO Soy free

MenaquinGold For 100% guaranteed potency

Additional Information

Vitamin Angels Proud Supporter Your purchase helps support the health of a child for an entire year.

Product Details

UPC / SKU 6 44216 44703 9
DSLD Entry Date 2024-11-22
Product Type Vitamin
Form Capsule
Brand Just Thrive
DSLD ID 319894
Data Updated 2026-04-11

Research Evidence

332 Research Sources
59 Avg Quality Score
220 Meta Analysis
56 Systematic Review
30 Rct
16 Clinical Trial
3 Guideline
3 Regulatory Source
1 Narrative Review
1 Other
1 Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014
View all evidence for Vitamin K →

Compare Similar Products

View all Vitamin K products →